Answers are grounded in this paper and cite their sources.
Rationale: Acquired haemophilia is a bleeding disorder caused by inhibitors developed against endogenous coagulation factors in patients, disrupting the normal haemostasis. Most of the cases with acquired haemophilia present with acquired FVIII inhibitors and FIX inhibitors. Acquired FXI inhibitors in patient without inherited FXI deficiency have rarely been reported. Here, we report a case of acquired factor XI inhibitors with primary Sjögren's syndrome. Patient concerns: A woman presented with dizziness and headache following a fall, and was diagnosed with skull fracture and epidural hematoma by computed tomography. Diagnoses: Acquired haemophilia with acquired factor XI inhibitor and primary Sjögren's syndrome. Interventions: She was treated with fresh frozen plasma and tranexamic acid for the first two days, and prednisolone (1 mg/kg/d) for 4 weeks, and a pulse infusion of cyclophosphamide, 750 mg/kg/dose, on the seventh day from the day of admission. Outcomes: Symptoms were improved without bleeding events. The inhibitor levels became undetectable and computed tomography revealed that the epidural hematoma was partly absorbed. Lessons: Factor XI inhibitor are rare, and the majority cases of the FXI inhibitors are associated with immune disorders and seem to respond well to immunosuppressive therapy.
No takes yet. Share an insight, caveat, or question.
Mi et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: